Talawar Therapeutics and JATT II Acquisition Corp. (Nasdaq: JATT) have entered into a definitive business combination agreement that would take ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE